Mindset Pharma Inc
CNSX:MSET
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Medicover AB
STO:MCOV B
|
SE |
Mindset Pharma Inc
Accrued Liabilities
Mindset Pharma Inc
Accrued Liabilities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Accrued Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
M
|
Mindset Pharma Inc
CNSX:MSET
|
Accrued Liabilities
CA$254.5k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Bausch Health Companies Inc
TSX:BHC
|
Accrued Liabilities
$3.3B
|
CAGR 3-Years
4%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
-1%
|
|
|
Canopy Growth Corp
TSX:WEED
|
Accrued Liabilities
CA$43.8m
|
CAGR 3-Years
-17%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
N/A
|
|
|
Cronos Group Inc
TSX:CRON
|
Accrued Liabilities
$36.5m
|
CAGR 3-Years
16%
|
CAGR 5-Years
95%
|
CAGR 10-Years
N/A
|
|
|
Mind Medicine (MindMed) Inc
NASDAQ:MNMD
|
Accrued Liabilities
$19m
|
CAGR 3-Years
36%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
K
|
Knight Therapeutics Inc
TSX:GUD
|
Accrued Liabilities
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Mindset Pharma Inc
Glance View
Mindset Pharma, Inc. is a pharmaceutical discovery and development company. The company is headquartered in Toronto, Ontario. The company went IPO on 2020-12-23. The firm is focused on developing patentable psychedelic compounds for the treatment of neurological and psychiatric disorders, with an initial focus on psilocybin-inspired new chemical entities (NCEs). Its drug development platform seeks to advance medicines based on psychedelic substances through rigorous scientific and clinical trials, performed by third-party contract research organizations. The firm intends to commercialize the psilocybin-inspired psychedelic medicines that it develops as regulated medicines.
See Also
What is Mindset Pharma Inc's Accrued Liabilities?
Accrued Liabilities
254.5k
CAD
Based on the financial report for Jun 30, 2022, Mindset Pharma Inc's Accrued Liabilities amounts to 254.5k CAD.
What is Mindset Pharma Inc's Accrued Liabilities growth rate?
Accrued Liabilities CAGR 1Y
48%
Over the last year, the Accrued Liabilities growth was 48%.
